» Articles » PMID: 22511596

Over-expression of RCAN1 Causes Down Syndrome-like Hippocampal Deficits That Alter Learning and Memory

Overview
Journal Hum Mol Genet
Date 2012 Apr 19
PMID 22511596
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

People with Down syndrome (DS) exhibit abnormal brain structure. Alterations affecting neurotransmission and signalling pathways that govern brain function are also evident. A large number of genes are simultaneously expressed at abnormal levels in DS; therefore, it is a challenge to determine which gene(s) contribute to specific abnormalities, and then identify the key molecular pathways involved. We generated RCAN1-TG mice to study the consequences of RCAN1 over-expression and investigate the contribution of RCAN1 to the brain phenotype of DS. RCAN1-TG mice exhibit structural brain abnormalities in those areas affected in DS. The volume and number of neurons within the hippocampus is reduced and this correlates with a defect in adult neurogenesis. The density of dendritic spines on RCAN1-TG hippocampal pyramidal neurons is also reduced. Deficits in hippocampal-dependent learning and short- and long-term memory are accompanied by a failure to maintain long-term potentiation (LTP) in hippocampal slices. In response to LTP induction, we observed diminished calcium transients and decreased phosphorylation of CaMKII and ERK1/2-proteins that are essential for the maintenance of LTP and formation of memory. Our data strongly suggest that RCAN1 plays an important role in normal brain development and function and its up-regulation likely contributes to the neural deficits associated with DS.

Citing Articles

Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.

Dohl J, Treadwell Z, Norris C, Head E Alzheimers Dement. 2025; 21(3):e70034.

PMID: 40042516 PMC: 11881635. DOI: 10.1002/alz.70034.


Inter- and transgenerational heritability of preconception chronic stress or alcohol exposure: Translational outcomes in brain and behavior.

Rice R, Gil D, Baratta A, Frawley R, Hill S, Farris S Neurobiol Stress. 2024; 29:100603.

PMID: 38234394 PMC: 10792982. DOI: 10.1016/j.ynstr.2023.100603.


Co-Occurrence of Congenital Aniridia Due to Nonsense Variant p.(Cys94*) and Chromosome 21 Trisomy in the Same Patient.

Vasilyeva T, Sukhanova N, Marakhonov A, Kuzina N, Shilova N, Kadyshev V Int J Mol Sci. 2023; 24(21).

PMID: 37958513 PMC: 10650867. DOI: 10.3390/ijms242115527.


Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach.

Abukhaled Y, Hatab K, Awadhalla M, Hamdan H J Neurol. 2023; 271(1):87-104.

PMID: 37561187 PMC: 10769995. DOI: 10.1007/s00415-023-11890-0.


Consequences of chromosome gain: A new view on trisomy syndromes.

Krivega M, Stiefel C, Storchova Z Am J Hum Genet. 2022; 109(12):2126-2140.

PMID: 36459979 PMC: 9808507. DOI: 10.1016/j.ajhg.2022.10.014.